THE FIRST AND SECOND GENERATION TYROSINE KINASE INHIBITORS ROLE IN THE PHILADELPHIA POSITIVE CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA

被引：0
|
作者：
Koc, Basak [1 ,2 ]
Zulfikar, Bulent [1 ,2 ]
机构：
[1] IU Cerrahpasa Med Fac, Istanbul, Turkey
[2] Inst Oncol, Istanbul, Turkey
来源：
PEDIATRIC BLOOD & CANCER | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
689
引用
收藏
页码：84 / 84
页数：1
相关论文
共 50 条
  • [41] Treatment of Philadelphia-positive acute lymphocytic leukemia with tyrosine kinase inhibitors: What is the optimal regimen?
    Fullmer, Amber
    Jabbour, Elias
    AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (03) : 158 - 159
  • [42] Allogeneic Stem Cell Transplantation versus Tyrosine Kinase Inhibitors Combined with Chemotherapy in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Wang, Jing
    Jiang, Qian
    Xu, Lan-ping
    Zhang, Xiao-hui
    Chen, Huan
    Qin, Ya-zhen
    Ruan, Guo-rui
    Jiang, Hao
    Jia, Jin-song
    Zhao, Ting
    Liu, Kai-Yan
    Jiang, Bin
    Huang, Xiao-Jun
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (04) : 741 - 750
  • [43] Growth of tyrosine kinase inhibitor-resistant Philadelphia-positive acute lymphoblastic leukemia: Role of bone marrow stromal cells
    Zhang, Cheng
    Zhang, Xi
    Yang, Shi-Jie
    Chen, Xing-Hua
    ONCOLOGY LETTERS, 2017, 13 (04) : 2059 - 2070
  • [44] ROLE OF SECOND GENERATION TYROSINE KINASE INHIBITORS IN OSTEOBLASTOGENESIS
    Tibullo, D.
    Barbagallo, I.
    Giallongo, I.
    La Cava, P.
    Branca, A.
    Bartolo, Di
    Spina, E.
    Spina, P.
    Del Fabro, V.
    Conticello, C.
    Romano, A.
    Palumbo, G.
    Di Raimondo, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 519 - 519
  • [45] The impact of tyrosine kinase inhibitors on allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
    Zhang, Yuanfeng
    Feng, Sizhou
    LEUKEMIA RESEARCH, 2021, 109
  • [46] Detection of Minimal Residual Leukemia Predicts the Outcome of Patients with Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia Treated with Tyrosine Kinase Inhibitors Plus Chemotherapy
    Ravandi, Farhad
    Thomas, Deborah A.
    O'Brien, Susan
    Garris, Rebecca
    Faderl, Stefan
    Shan, Jianqin
    Borthakur, Gautam
    Burger, Jan A.
    Ferrajoli, Alessandra
    Kebriaei, Partow
    Champlin, Richard
    Estrov, Zeev
    Wang, Sa A.
    Jorgensen, Jeffrey L.
    Luthra, Rajyalakshmi
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    BLOOD, 2011, 118 (21) : 631 - 632
  • [47] Prognostic Significance of Immunophenotypic and Karyotypic Features of Philadelphia Positive B-Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors
    Jaso, Jesse
    Thomas, Deborah A.
    Cunningham, Krista
    Jorgensen, Jeffrey L.
    Kantarjian, Hagop M.
    Medeiros, L. Jeffrey
    Wang, Sa A.
    CANCER, 2011, 117 (17) : 4009 - 4017
  • [48] Ponatinib: A New Tyrosine Kinase Inhibitor for the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Shamroe, Caitlin L.
    Comeau, Jill M.
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (11) : 1540 - 1546
  • [49] Drug Resistance and BCR-ABL Kinase Domain Mutations in Philadelphia Chromosome- Positive Acute Lymphoblastic Leukemia From the Imatinib to the Second- Generation Tyrosine Kinase Inhibitor Era
    Soverini, Simona
    De Benedittis, Caterina
    Papayannidis, Cristina
    Paolini, Stefania
    Venturi, Claudia
    Iacobucci, Ilaria
    Luppi, Mario
    Bresciani, Paola
    Salvucci, Marzia
    Russo, Domenico
    Sica, Simona
    Orlandi, Ester
    Intermesoli, Tamara
    Gozzini, Antonella
    Bonifacio, Massimiliano
    Rigolin, Gian Matteo
    Pane, Fabrizio
    Baccarani, Michele
    Cavo, Michele
    Martinelli, Giovanni
    CANCER, 2014, 120 (07) : 1002 - 1009
  • [50] Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working Party
    Hirschbuehl, Klaus
    Labopin, Myriam
    Houhou, Mohamed
    Gabellier, Ludovic
    Labussiere-Wallet, Helene
    Lioure, Bruno
    Beelen, Dietrich
    Cornelissen, Jan
    Wulf, Gerald
    Jindra, Pavel
    Tilly, Herve
    Passweg, Jakob
    Niittyvuopio, Riita
    Bug, Gesine
    Schmid, Christoph
    Nagler, Arnon
    Giebel, Sebastian
    Mohty, Mohamad
    BONE MARROW TRANSPLANTATION, 2021, 56 (05) : 1190 - 1199
12345